Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
- PMID: 24300695
- DOI: 10.1016/j.neubiorev.2013.11.009
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Abstract
Chronic stressful life events are risk factors for developing major depression, the pathophysiology of which is strongly linked to impairments in serotonin (5-HT) neurotransmission. Exposure to chronic unpredictable stress (CUS) has been found to induce depressive-like behaviours, including passive behavioural coping and anhedonia in animal models, along with many other affective, cognitive, and behavioural symptoms. The heterogeneity of these symptoms represents the plurality of corticolimbic structures involved in mood regulation that are adversely affected in the disorder. Chronic stress has also been shown to negatively regulate adult hippocampal neurogenesis, a phenomenon that is involved in antidepressant effects and regulates subsequent stress responses. Although there exists an enormous body of data on stress-induced alterations of 5-HT activity, there has not been extensive exploration of 5-HT adaptations occurring presynaptically or at the level of the raphe nuclei after exposure to CUS. Similarly, although hippocampal neurogenesis is known to be negatively regulated by stress and positively regulated by antidepressant treatment, the role of neurogenesis in mediating affective behaviour in the context of stress remains an active area of investigation. The goal of this review is to link the serotonergic and neurogenic hypotheses of depression and antidepressant effects in the context of stress. Specifically, chronic stress significantly attenuates 5-HT neurotransmission and 5-HT1A autoreceptor sensitivity, and this effect could represent an endophenotypic hallmark for mood disorders. In addition, by decreasing neurogenesis, CUS decreases hippocampal inhibition of the hypothalamic-pituitary-adrenal (HPA) axis, exacerbating stress axis overactivity. Similarly, we discuss the possibility that adult hippocampal neurogenesis mediates antidepressant effects via the ventral (in rodents; anterior in humans) hippocampus' influence on the HPA axis, and mechanisms by which antidepressants may reverse chronic stress-induced 5-HT and neurogenic changes. Although data are as yet equivocal, antidepressant modulation of 5-HT neurotransmission may well serve as one of the factors that could drive neurogenesis-dependent antidepressant effects through these stress regulation-related mechanisms.
Keywords: Antidepressant; Chronic unpredictable stress; Depression; Hypothalamic–pituitary–adrenal axis; Neurogenesis; Neurotrophic factors; Serotonin; Stress.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?Neuroscience. 2013 Nov 12;252:234-52. doi: 10.1016/j.neuroscience.2013.08.017. Epub 2013 Aug 20. Neuroscience. 2013. PMID: 23973415 Review.
-
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress.Eur Neuropsychopharmacol. 2009 Mar;19(3):215-28. doi: 10.1016/j.euroneuro.2008.11.005. Epub 2009 Jan 15. Eur Neuropsychopharmacol. 2009. PMID: 19147333
-
Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis.Hippocampus. 2013 Sep;23(9):797-811. doi: 10.1002/hipo.22134. Epub 2013 May 22. Hippocampus. 2013. PMID: 23592526
-
Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review.
-
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.Behav Pharmacol. 2007 Sep;18(5-6):391-418. doi: 10.1097/FBP.0b013e3282ee2aa8. Behav Pharmacol. 2007. PMID: 17762509 Review.
Cited by
-
The Impact of Depression on Detrimental Changes in Bone Microstructure in Female Mice.Neuropsychiatr Dis Treat. 2024 Jul 18;20:1421-1433. doi: 10.2147/NDT.S454865. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 39049938 Free PMC article.
-
Reducing Allostatic Load in Depression and Anxiety Disorders: Physical Activity and Yoga Practice as Add-On Therapies.Front Psychiatry. 2020 Jun 4;11:501. doi: 10.3389/fpsyt.2020.00501. eCollection 2020. Front Psychiatry. 2020. PMID: 32581876 Free PMC article. Review.
-
White matter integrity and medication response to antidepressants in major depressive disorder: a review of the literature.Front Psychiatry. 2024 Feb 1;14:1335706. doi: 10.3389/fpsyt.2023.1335706. eCollection 2023. Front Psychiatry. 2024. PMID: 38361831 Free PMC article. Review.
-
Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus.Neurochem Res. 2016 Sep;41(9):2352-66. doi: 10.1007/s11064-016-1949-2. Epub 2016 May 21. Neurochem Res. 2016. PMID: 27209303
-
Relationship between nightmare distress and depressive symptoms in Chinese emergency department nurses: A cross-sectional study.World J Psychiatry. 2023 Dec 19;13(12):1087-1095. doi: 10.5498/wjp.v13.i12.1087. eCollection 2023 Dec 19. World J Psychiatry. 2023. PMID: 38186729 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical